Last reviewed · How we verify
KyungBangn-Gamisoyosan-x-gwarip
KyungBangn-Gamisoyosan-x-gwarip is a Small molecule drug developed by Korea Health Industry Development Institute. It is currently in Phase 3 development for Immune-related conditions (specific indication unclear from available information). Also known as: standard code for item : 200005799.
KyungBangn-Gamisoyosan-x-gwarip is a traditional Korean herbal medicine formulation designed to modulate immune and inflammatory responses.
KyungBangn-Gamisoyosan-x-gwarip is a traditional Korean herbal medicine formulation designed to modulate immune and inflammatory responses. Used for Immune-related conditions (specific indication unclear from available information).
At a glance
| Generic name | KyungBangn-Gamisoyosan-x-gwarip |
|---|---|
| Also known as | standard code for item : 200005799 |
| Sponsor | Korea Health Industry Development Institute |
| Modality | Small molecule |
| Therapeutic area | Immunology |
| Phase | Phase 3 |
Mechanism of action
This is a polyherbal preparation based on traditional Korean medicine principles, combining multiple botanical ingredients to address immune dysregulation and inflammatory conditions. The exact molecular mechanisms are not well-characterized in modern pharmacological terms, as the drug represents a complex mixture of plant-derived compounds rather than a single targeted agent.
Approved indications
- Immune-related conditions (specific indication unclear from available information)
Common side effects
Key clinical trials
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- KyungBangn-Gamisoyosan-x-gwarip CI brief — competitive landscape report
- KyungBangn-Gamisoyosan-x-gwarip updates RSS · CI watch RSS
- Korea Health Industry Development Institute portfolio CI
Frequently asked questions about KyungBangn-Gamisoyosan-x-gwarip
What is KyungBangn-Gamisoyosan-x-gwarip?
How does KyungBangn-Gamisoyosan-x-gwarip work?
What is KyungBangn-Gamisoyosan-x-gwarip used for?
Who makes KyungBangn-Gamisoyosan-x-gwarip?
Is KyungBangn-Gamisoyosan-x-gwarip also known as anything else?
What development phase is KyungBangn-Gamisoyosan-x-gwarip in?
Related
- Manufacturer: Korea Health Industry Development Institute — full pipeline
- Therapeutic area: All drugs in Immunology
- Indication: Drugs for Immune-related conditions (specific indication unclear from available information)
- Also known as: standard code for item : 200005799
- Compare: KyungBangn-Gamisoyosan-x-gwarip vs similar drugs
- Pricing: KyungBangn-Gamisoyosan-x-gwarip cost, discount & access